Skip to main content
SpringerLink
Log in

The Obsessive-Compulsive Dimension

  • Chapter
  • First Online:
Dimensional Psychopathology

  • 804 Accesses

Abstract

Obsessive-compulsive disorder (OCD) is a clinical syndrome characterised by recurrent intrusive thoughts (obsessions) and repetitive mental or behavioural acts (compulsions), typically performed in response to obsessions or related anxiety. OCD generally has a stable symptom pattern throughout life but nevertheless is well known for its heterogeneity, as symptomatic presentations and comorbidity patterns differ widely among patients. A number of other psychiatric and neurological disorders may share similar phenomenological characteristics with OCD or are sometimes conceptualised as atypical OCDs. These heterogeneous aspects of the disorder have led to a search for OCD subtypes that might be associated with different aetiologies or treatment responses.

In the past few decades, the predominant models of OCD pathophysiology have focused on cortico-striatal circuitry, but more recent neuroimaging studies implicate involvement of the lateral and medial orbitofrontal cortices, the dorsal anterior cingulate cortex, and the amygdalo-cortical circuitry, in addition to cortico-striatal circuitry, in the pathophysiology of this disorder.

In this chapter, we have highlighted how a dimensional approach can offer opportunities for better assessment and more effective treatment than categorical diagnosis. The usefulness of this approach is based on the fact that the obsessive psychopathological dimension can be found in a number of syndromes and that treatment can be provided for it independently of the baseline disorder. For this purpose, our patients have been assessed with the SVARAD and treated accordingly, taking into account the particulars of each individual case.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kraepelin E. Psychiatrie. Ein Lehrbuch für Studierende und Ärzte Klinische Psychiatrie. Leipzig: Barth; 1915.

    Google Scholar 

  2. Jaspers K. Allgemeine Psychopathologie. 5th ed. Berlin: Springer; 1948.

    Google Scholar 

  3. Krafft-Ebing R. Űber Geisterstörungen durch Zwangsvorstellung. Allg Z Psychiatr. 1879;35:303–28.

    Google Scholar 

  4. Westphal C. Űber Zwangsvorstellung. Arch Psychiatr Nervenkr. 1872;3:138–61.

    Article  Google Scholar 

  5. Janet P. Les Obsessions et la Psychasthenié. Paris: Alcan; 1919.

    Google Scholar 

  6. Falret JP. Obsession intellectuelles et emotives. Arch Neurolog. 1889;2:274–93.

    Google Scholar 

  7. Berrios GE. The history of mental symptoms. Cambridge: Cambridge Univeristy Press; 1996.

    Book  Google Scholar 

  8. Hollander E, Schiffman E, Cohen B, Rivera-Stein MA, Rosen W, Gorman JM, Fyer AJ, Papp L, Liebowitz MR. Signs of central nervous system dysfunction in obsessive-compulsive disorder. Arch Gen Psychiatry. 1990;47(1):27–32.

    Article  PubMed  CAS  Google Scholar 

  9. Hollander E. Obsessive-compulsive spectrum disorders: an overview. Psychiatr Ann. 1993;23(7):355–8.

    Article  Google Scholar 

  10. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd edition, revised. Washington, DC: American Psychiatric Association; 1987.

    Google Scholar 

  11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.

    Book  Google Scholar 

  12. Torres AR, Prince MJ, Bebbington PE, Bhugra D, Brugha TS, Farrell M, Jenkins R, Lewis G, Meltzer H, Singleton N. Obsessive-compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000. Am J Psychiatry. 2006;163(11):1978–85.

    Article  PubMed  Google Scholar 

  13. Crino R, Slade T, Andrews G. The changing prevalence and severity of obsessive-compulsive disorder criteria from DSM-III to DSM-IV. Am J Psychiatry. 2005;162(5):876–82.

    Article  PubMed  Google Scholar 

  14. Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(1):53–63.

    Article  CAS  PubMed  Google Scholar 

  15. Castle DJ, Phillips KA. Obsessive–compulsive spectrum of disorders: a defensible. Aust N Z J Psychiatry. 2006;40(2):114–20.

    PubMed  PubMed Central  Google Scholar 

  16. Fullana MA, Mataix-Cols D, Caspi A, Harrington H, Grisham JR, Moffitt TE, Poulton R. Obsessions and compulsions in the community: prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions. Am J Psychiatry. 2009;166(3):329–36.

    Article  PubMed  Google Scholar 

  17. Clark DA. Innovation in obsessive compulsive disorder: A commentary. J Behav Ther Exp Psychiatry. 2015;49(Pt B):129–32.

    Article  PubMed  Google Scholar 

  18. Berry LM, Laskey B. A review of obsessive-compulsive thoughts in the general population. J Obsessive Compulsive Relat Disord. 2012;1:125–32.

    Article  Google Scholar 

  19. Berthier ML, Kulisevsky J, Gironell A, Heras JA. Obsessive-compulsive disorder associated with brain lesions: clinical phenomenology, cognitive function, and anatomic correlates. Neurology. 1996;47:353–61.

    Article  PubMed  CAS  Google Scholar 

  20. Carmin CN, Wiegartz PS, Yunus U, Gillock KL. Treatment of late-onset OCD following basal ganglia infarct. Depress Anxiety. 2002;15:87–90.

    Article  PubMed  Google Scholar 

  21. Murphy DL, Timpano KR, Wheaton MG, Greenberg BD, Miguel EC. Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts. Dialogues Clin Neurosci. 2010;12:131–48.

    PubMed  PubMed Central  Google Scholar 

  22. Bolton D, Gibb W, Lees A, Raven P, Gray JA, Chen E, et al. Neurological soft signs in obsessive compulsive disorder: standardised assessment and comparison with schizophrenia. Behav Neurol. 1998;11:197–204.

    Article  PubMed  Google Scholar 

  23. Milad MR, Rauch SL. Obsessive compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci. 2012;16(1):43–51.

    Article  PubMed  Google Scholar 

  24. Breiter HC, Rauch SL. Functional MRI and the study of OCD: From symptom provocation to cognitive-behavioral probes of cortico-striatal systems and the amygdala. NeuroImage. 1996;4(3 Pt 3):127–38.

    Article  Google Scholar 

  25. Harrison BJ, Soriano-Mas C, Pujol J, Ortiz H, López-Solà M, Hernández-Ribas R, Deus J, Alonso P, Yücel M, Pantelis C, Menchon JM, Cardoner N. Altered corticostriatal functional connectivity in obsessive-compulsive disorder. Arch Gen Psychiatry. 2009;66(11):1189–200.

    Article  PubMed  Google Scholar 

  26. Szeszko PR, Robinson D, Alvir JM, Bilder RM, Lencz T, Ashtari M, et al. Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry. 1999;56:913–9.

    Article  PubMed  CAS  Google Scholar 

  27. Rotge J-Y, Guehl D, Dilharreguy B, Tignol J, Bioulac B, Allard M, et al. Meta-analysis of brain volume changes in obsessive-compulsive disorder. Biol Psychiatry. 2009;65(1):75–83.

    Article  PubMed  Google Scholar 

  28. Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am. 2000;23:563–86.

    Article  PubMed  CAS  Google Scholar 

  29. Saxena S, Bota RG, Brody AL. Brain-behavior relationships in obsessive-compulsive disorder. Semin Clin Neuropsychiatry. 2001;6(2):82–101.

    Article  PubMed  CAS  Google Scholar 

  30. Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res. 2004;132(1):69–79.

    Article  PubMed  Google Scholar 

  31. Nordahl TE, Benkelfat C, Semple WE, Gross M, King AC, Cohen RM. Cerebral glucose metabolic rates in obsessive compulsive disorder. Neuropsychopharmacology. 1989;2:23–8.

    Article  PubMed  CAS  Google Scholar 

  32. Benkelfat C, Nordahl TE, Semple WE, King AC, Murphy DL, Cohen RM. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. Arch Gen Psychiatry. 1990;47:840–8.

    Article  PubMed  CAS  Google Scholar 

  33. Perani D, Colombo C, Bressi S, Bonfanti A, Grassi F, Scarone S, et al. [18F] FDG PET study in obsessive-compulsive disorder A clinical/metabolic correlation study after treatment. Br J Psychiatry. 1995;166:244–50.

    Article  PubMed  CAS  Google Scholar 

  34. Hoehn-Saric R, Schlaepfer TE, Greenberg BD, McLeod DR, Pearlson GD, Wong SH. Cerebral blood flow in obsessive-compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders. Psychiatry Res. 2001;108:89–100.

    Article  PubMed  CAS  Google Scholar 

  35. Hansen ES, Hasselbalch S, Law I, Bolwig TG. The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study. Int J Neuropsychopharmacol. 2002;5:1–10.

    Article  PubMed  CAS  Google Scholar 

  36. Baxter LR Jr, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry. 1992;49:681–9.

    Article  PubMed  CAS  Google Scholar 

  37. Brody AL, Saxena S, Schwartz JM. FDG-PET predictors of response to behaviour therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Res. 1998;84:1–6.

    Article  PubMed  CAS  Google Scholar 

  38. Kang DH, Kwon JS, Kim JJ, Youn T, Park HJ, Kim MS, et al. Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessive-compulsive disorder. Acta Psychiatr Scand. 2003;107:291–7.

    Article  PubMed  Google Scholar 

  39. Arnsten Amy FT. Catecholamine influences on dorsolateral prefrontal cortical networks. Biol Psychiatry. 2011;69(12):89–99.

    Article  CAS  Google Scholar 

  40. Apostolova I, Block S, Buchert R, Osen B, Conradi M, Tabrizian S, et al. Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive-compulsive disorder as assessed by brain FDG PET. Psychiatry Res. 2010;184:105–16.

    Article  PubMed  CAS  Google Scholar 

  41. Ho Pian KL, van Megen HJ, Ramsey NF, Mandl R, van Rijk PP, Wynne HJ, et al. Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine. Psychiatry Res. 2005;138:89–97.

    Article  PubMed  CAS  Google Scholar 

  42. Yücel M, Wood SJ, Wellard RM, Harrison BJ, Fornito A, Pujol J, et al. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder. Aust N Z J Psychiatry. 2008;42:467–77.

    Article  PubMed  Google Scholar 

  43. Brennan BP, Rauch SL, Jensen JE, Pope HG Jr. A critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorder. Biol Psychiatry. 2013;73(1):24–31.

    Article  PubMed  Google Scholar 

  44. Adler CM, McDonough-Ryan P, Sax KW, Holland SK, Arndt S, Strakowski SM. fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder. J Psychiatr Res. 2000;34:317–24.

    Article  PubMed  CAS  Google Scholar 

  45. Nakao T, Nakagawa A, Yoshiura T, Nakatani E, Nabeyama M, Yoshizato C, et al. Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study. Biol Psychiatry. 2005;57:901–10.

    Article  PubMed  Google Scholar 

  46. Kang DH, Jang JH, Han JY, Kim JH, Jung WH, Choi JS, et al. Neural correlates of altered response inhibition and dysfunctional connectivity at rest in obsessive-compulsive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013;40:340–6.

    Article  Google Scholar 

  47. Tian L, Meng C, Jiang Y, Tang Q, Wang S, Xie X, et al. Abnormal functional connectivity of brain network hubs associated with symptom severity in treatment-naive patients with obsessive compulsive disorder: a resting-state functional MRI study. Prog Neuropsychopharmacol Biol Psychiatry. 2016;66:104–11.

    Article  PubMed  Google Scholar 

  48. Bernstein GA, Mueller BA, Schreiner MW, Campbell SM, Regan EK, Nelson PM, et al. Abnormal striatal resting-state functional connectivity in adolescents with obsessive-compulsive disorder. Psychiatry Res. 2016;247:49–56.

    Article  Google Scholar 

  49. Nakatani E, Nakgawa A, Ohara Y, Goto S, Uozumi N, Iwakiri M, et al. Effects of behavior therapy on regional cerebral blood flow in obsessive-compulsive disorder. Psychiatry Res. 2003;124:113–20.

    Article  PubMed  Google Scholar 

  50. Freyer T, Klöppel S, Tüscher O, Kordon A, Zurowski B, Kuelz AK, et al. Frontostriatal activation in patients with obsessive-compulsive disorder before and after cognitive behavioral therapy. Psychol Med. 2011;41:207–16.

    Article  PubMed  CAS  Google Scholar 

  51. Rauch SL, Savage CR. Neuroimaging and neuropsychology of the striatum. Bridging basic science and clinical practice. Psychiatr Clin North Am. 1997;20:741–68.

    Article  PubMed  CAS  Google Scholar 

  52. Fineberg NA, Sivakumaran T, Roberts A, Gale T. Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study. Int Clin Psychopharmacol. 2005;20(4):223–6.

    Article  PubMed  Google Scholar 

  53. Fineberg NA, Gale TM, Sivakumaran T. A review of antipsychotics in the treatment of obsessive compulsive disorder. J Psychopharmacol. 2006;20(1):97–103.

    Article  PubMed  CAS  Google Scholar 

  54. Gillan CM, Fineberg NA, Robbins TW. A trans-diagnostic perspective on obsessive-compulsive disorder. Psychol Med. 2017;47(9):1528–48.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  55. Gillan CM, Papmeyer M, Morein-Zamir S, Sahakian BJ, Fineberg NA, Robbins TW, et al. Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder. Am J Psychiatry. 2011;168:718–26.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Voon V, Reiter A, Sebold M, Groman S. Model-based control in dimensional psychiatry. Biol Psychiatry. 2017;82(6):391–400.

    Article  PubMed  Google Scholar 

  57. Fontenelle LF, Oostermeijer S, Harrison BJ, Pantelis C, Yucel M. Obsessive-compulsive disorder, impulse control disorders and drug addiction: common features and potential treatments. Drugs. 2011;71:827–40.

    Article  PubMed  CAS  Google Scholar 

  58. Sjoerds Z, de Wit S, van den Brink W, Robbins TW, Beekman AT, Penninx BW, Veltman DJ. Behavioral and neuroimaging evidence for overreliance on habit learning in alcohol-dependent patients. Transl Psychiatry. 2013;3(12):e33.

    Article  Google Scholar 

  59. Voon V, Derbyshire K, Rück C, Irvine MA, Worbe Y, Enander J, Schreiber LR, Gillan C, Fineberg NA, Sahakian BJ, Robbins TW, Harrison NA, Wood J, Daw ND, Dayan P, Grant JE, Bullmore ET. Disorders of compulsivity: a common bias towards learning habits. Mol Psychiatry. 2015;20(3):345–52.

    Article  PubMed  CAS  Google Scholar 

  60. Pancheri P, et al. Validazione della scala per la valutazione rapida dimensionale “SVARAD”. Riv Psichiatr. 1999;34:84–93.

    Google Scholar 

  61. Bellodi L. Diagnosi differenziale e casi clinici. In: Smeraldi E, editor. Il disturbo Ossessivo-Compulsivo e il suo spettro, vol. 2003. Milano: Masson; 2003. p. 303–26.

    Google Scholar 

  62. Berman I, Merson A, Viegner B, Losonczy MF, Pappas D, Green AI. Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study. J Nerv Ment Dis. 1998;186:150–6.

    Article  PubMed  CAS  Google Scholar 

  63. Bland RC, Newman SC, Orn H. Schizophrenia: lifetime comorbidity in a community sample. Acta Psychiatr Scand. 1987;75:383–91.

    Article  PubMed  CAS  Google Scholar 

  64. de Haan L, Dudek-Hodge C, Verhoeven Y, Denys D. Prevalence of psychotic disorders in patients with obsessive-compulsive disorder. CNS Spectr. 2009;14(8):415–7.

    Article  PubMed  Google Scholar 

  65. Porto L, Bermanzohn PC, Pollack S, Morrissey R, Siris SG. A profile of obsessive-compulsive symptoms in schizophrenia. CNS Spectr. 1997;2:21–5.

    Article  Google Scholar 

  66. Bottas A, Cooke RG, Richter MA. Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia? J Psychiatry Neurosci. 2005;30(3):187–93.

    PubMed  PubMed Central  Google Scholar 

  67. Poyurovsky M, Koran LM. Obsessive-compulsive disorder (OCD) with schizotypy vs. schizophrenia with OCD: diagnostic dilemmas and therapeutic implications. J Psychiatr Res. 2005;39:399–408.

    Article  PubMed  CAS  Google Scholar 

  68. Rosen I. The clinical significance of obsessions in schizophrenia. J Ment Sci. 1957;103:773–85.

    Article  PubMed  CAS  Google Scholar 

  69. Hwang MY, Morgan JE, Losconzcy MF. Clinical and neuropsychological profiles of obsessive–compulsive schizophrenia: a pilot study. J Neuropsychiatry Clin Neurosci. 2000;12:91–4.

    Article  PubMed  CAS  Google Scholar 

  70. Niendam TA, Berzaka J, Cannon TD, Bearden CE. Obsessive compulsive symptoms in the psychosis prodrome: correlates of clinical and functional outcome. Schizophr Res. 2009;108(1–3):170–5.

    Article  PubMed  Google Scholar 

  71. Öngür D, Goff DC. Obsessive-compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status. Schizophr Res. 2005;75:349–62.

    Article  PubMed  Google Scholar 

  72. Lim M, Park DY, Kwon JS, Joo YH, Hong KS. Prevalence and clinical characteristics of obsessive-compulsive symptoms associated with atypical antipsychotics. J Clin Psychopharmacol. 2007;27(6):712–3.

    Article  PubMed  CAS  Google Scholar 

  73. Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, Haukka J. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009;374(9690):620–7.

    Article  PubMed  Google Scholar 

  74. Englisch S, Esslinger C, Inta D, et al. Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazole. Clin Neuropharmacol. 2009;32:4,227–9.

    Article  CAS  Google Scholar 

  75. Kim SW, Shin IS, Kim JM, Yang SJ, Hwang MY, Yoon JS. Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study. J Clin Psychopharmacol. 2008;28(3):349–52.

    Article  PubMed  Google Scholar 

  76. Tundo A, Necci R. Cognitive-behavioural therapy for obsessive-compulsive disorder co-occurring with psychosis systematic review of evidence. World J Psychiatry. 2016;6(4):449–55.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Adam Y, Meinlschmidt G, Gloster AT, Lieb R. Obsessive-compulsive disorder in the community: 12-month prevalence, comorbidity and impairment. Soc Psychiatry Psychiatr Epidemiol. 2012;47(3):339–49.

    Article  PubMed  Google Scholar 

  78. Leone JE, Sedory EJ, Gray KA. Recognition and treatment of muscle dysmorphia and related body image disorders. J Athl Train. 2005;40(4):352–9.

    PubMed  PubMed Central  Google Scholar 

  79. Davidson J. Diabulimia: how eating disorders can affect adolescents with diabetes. Nurs Stand. 2014;29(2):44–9.

    Article  PubMed  Google Scholar 

  80. Roosen KM, Mills JS. Exploring the motives and mental health correlates of intentional food restriction prior to alcohol use in university students. J Health Psychol. 2015;20(6):875–86.

    Article  PubMed  Google Scholar 

  81. Mathieu J. What is pregorexia? J Am Diet Assoc. 2009;109(6):976–9.

    Article  PubMed  Google Scholar 

  82. Mathieu J. What is orthorexia? J Am Diet Assoc. 2005;105(10):1510–2.

    Article  PubMed  Google Scholar 

  83. Donini LM, Marsili D, Graziani MP, Imbriale M, Cannella C. Orthorexia nervosa: a preliminary study with a proposal for diagnosis and an attempt to measure the dimension of the phenomenon. Eat Weight Disord. 2004;9(2):151–7.

    Article  PubMed  CAS  Google Scholar 

  84. Dunn TM, Bratman S. On orthorexia nervosa: a review of the literature and proposed diagnostic criteria. Eat Behav. 2015;21:11–7.

    Article  PubMed  Google Scholar 

  85. Halmi KA, Tozzi F, Thornton LM, et al. The relation among perfectionism, obsessive-compulsive personality disorder and obsessive-compulsive disorder in individuals with eating disorders. Int J Eat Disord. 2005;38(4):371–4.

    Article  PubMed  Google Scholar 

  86. Dell'Osso L, Abelli M, Carpita B, Pini S, Castellini G, Carmassi C, Ricca V. Historical evolution of the concept of anorexia nervosa and relationships with orthorexia nervosa, autism, and obsessive-compulsive spectrum. Neuropsychiatr Dis Treat. 2016;12:1651–60.

    Article  PubMed  PubMed Central  Google Scholar 

  87. McKay D, Sookman D, Neziroglu F, Wilhelm S, Stein DJ, Kyrios M, Matthews K, Veale D. Accreditation task force of the Canadian Institute for Obsessive Compulsive Disorders. Efficacy of cognitive-behavioral therapy for obsessive-compulsive disorder. Psychiatry Res. 2015;227(1):104–13.

    Article  PubMed  Google Scholar 

  88. Fullana MA, Zhu X, Alonso P, Cardoner N, Real E, López-Solà C, Segalàs C, Subirà M, Galfalvy H, Menchón JM, Simpson HB, Marsh R, Soriano-Mas C. Basolateral amygdala-ventromedial prefrontal cortex connectivity predicts cognitive behavioural therapy outcome in adults with obsessive-compulsive disorder. J Psychiatry Neurosci. 2017;42(5):160215.

    Google Scholar 

  89. Külz A, Barton B, Voderholzer U. Third wave therapies of cognitive behavioral therapy for obsessive compulsive disorder: a reasonable add-on therapy for CBT? State of the art. Psychother Psychosom Med Psychol. 2016;66(3–4):106–11.

    PubMed  Google Scholar 

  90. Downar J, Geraci J, Salomons TV, Dunlop K, Wheeler S, McAndrews MP, et al. Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression. Biol Psychiatry. 2014;76:176–85.

    Article  PubMed  Google Scholar 

  91. Dunlop K, Woodside B, Olmsted M, Colton P, Giacobbe P, Downar J. Reductions in cortico-striatal hyperconnectivity accompany successful treatment of obsessive-compulsive disorder with dorsomedial prefrontal rTMS. Neuropsychopharmacology. 2016;41:1395–403.

    Article  PubMed  CAS  Google Scholar 

  92. Denys D, Mantione M, Figee M, van den Munckhof P, Koerselman F, Westenberg H, et al. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry. 2010;67:1061–8.

    Article  PubMed  Google Scholar 

  93. Aouizerate B, Cuny E, Martin-Guehl C, Guehl D, Amieva H, Benazzouz A, et al. Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive—compulsive disorder and major depression. J Neurosurg. 2004;101:682–6.

    Article  PubMed  Google Scholar 

  94. Ruffini C, Locatelli M, Lucca A, Benedetti F, Insacco C, Smeraldi E. Augmentation effect of repetitive transcranial magnetic stimulation over the orbitofrontal cortex in drug-resistant obsessive-compulsive disorder patients: a controlled investigation. Prim Care Companion J Clin Psychiatry. 2009;11:226–30.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Nauczyciel C, Le Jeune F, Naudet F, Douabin S, Esquevin A, Vérin M, et al. Repetitive transcranial magnetic stimulation over the orbitofrontal cortex for obsessive-compulsive disorder: a double-blind, crossover study. Transl Psychiatry. 2014;4:e436.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  96. Mondino M, Haesebaert F, Poulet E, Saoud M, Brunelin J. Efficacy of cathodal transcranial direct current stimulation over the left orbitofrontal cortex in a patient with treatment-resistant obsessive-compulsive disorder. J ECT. 2015;31:271–2.

    Article  PubMed  Google Scholar 

  97. Bation R, Poulet E, Haesebaert F, Saoud M, Brunelin J. Transcranial direct current stimulation in treatment-resistant obsessive compulsive disorder: an open-label pilot study. Prog Neuro-Psychopharmacol Biol Psychiatry. 2016;65:153–7.

    Article  Google Scholar 

  98. Fettes P, Schulze L, Downar J. Cortico-striatal-thalamic loop circuits of the orbitofrontal cortex: promising therapeutic targets in psychiatric illness. Front Syst Neurosci. 2017;11:25.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Cunill R, Castells X, Simeon D. Relationships between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis. J Clin Psychiatry. 2009;70(1):70–82.

    Article  PubMed  Google Scholar 

  100. Fineberg NA, Saxena S, Zohar J, Craig KJ. Obsessive-compulsive disorder. In: Hollander E, Zohar J, Sirovatka PJ, Regier DA, editors. Obsessive-compulsive spectrum disorders. Arlington: American Psychiatric Publishing; 2011. p. 9–10.

    Google Scholar 

  101. Bahnson CB, Kissen DM. Psychophysiological aspects of cancer. Ann N Y Acad Sci. 1966;125:775–1055.

    Google Scholar 

  102. Bellodi L, Erzegovesi S. Disturbi dell’alimentazione. In: Smeraldi E, editor. Il disturbo Ossessivo-Compulsivo e il suo spettro. Milano: Masson; 2003. p. 489–544.

    Google Scholar 

  103. Hirschtritt ME, Bloch MH, Mathews CA. Obsessive-compulsive disorder: advances in diagnosis and treatment. JAMA. 2017;317(13):1358–67.

    Article  PubMed  Google Scholar 

  104. Piacentino D, Pasquini M, Tarsitani L, Berardelli I, Roselli V, Maraone A, Biondi M. The Association of Anger with symptom subtypes in severe obsessive-compulsive disorder outpatients. Psychopathology. 2016;49(1):40–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy

    Ines Taddei, Martina Valentini & Massimo Pasquini

Authors
  1. Ines Taddei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martina Valentini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Massimo Pasquini
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Human Neurosciences, Policlinico Umberto I Hospital, Sapienza University of Rome, Rome, Italy

    Massimo Biondi

  2. Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy

    Massimo Pasquini

  3. Centre for Behavioural Sciences and Mental Health, Italian National Institute of Health, Rome, Italy

    Angelo Picardi

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Taddei, I., Valentini, M., Pasquini, M. (2018). The Obsessive-Compulsive Dimension. In: Biondi, M., Pasquini, M., Picardi, A. (eds) Dimensional Psychopathology. Springer, Cham. https://doi.org/10.1007/978-3-319-78202-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-78202-7_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-78201-0

  • Online ISBN: 978-3-319-78202-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation